Investor Presentation • Nov 6, 2025
Investor Presentation
Open in ViewerOpens in native device viewer

This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and 21E of the Securities Exchange Act of 1934, as amended, which provides a "safe harbor" for such statements in certain circumstances. When used in this presentation, the words "anticipates," "may," "believes," "expects," "intends," "plans," "estimates," "predicts," the negative expressions of such words, or similar expressions and any other statements that are not historical facts are intended to identify those assertions as forward- looking statements. All statements that address activities, events or developments that Arq, Inc. ("we," "us," "our," "Arq" or the "Company") intends, expects or believes may occur in the future are forward-looking statements. These forward-looking statements include, but are not limited to, statements or expectations regarding: our ability to complete and the anticipating timing of the ramp-up to full nameplate capacity at our Red River Plant; the anticipated timing of a final investment decision regarding a potential second GAC Facility at the Red River Plant and our ability to execute on such a project; the potential operational and financial benefits of using lower-moisture coal to manufacture our GAC products; the anticipated effects from fluctuations in the pricing of our AC products; expected supply, demand and growth opportunities for our AC products and services, including our GAC products; the seasonal impact on our customers and their demand for our products; our ability to fund our business over the next twelve months; our ability to access new markets for our feedstocks, GAC and other products, including renewable natural gas, asphalt, purified coal, rare earth minerals and synthetic graphite markets; future growth in the industries in which we currently operate or intend to operate, including renewable natural gas; any future plant capacity expansions or site development projects, the timing thereof and our ability to finance any such projects; the effectiveness of our technologies and products and the benefits they provide, including in potential new markets and applications; the timing of awards or extensions of, and work and related testing under, our contracts and agreements and their value; our ability to contract remaining GAC product volumes; future cash flows, profitability and other potential benefits expected from our GAC business; the future profitability and sustainability of our PAC business; the timing and amounts of or changes in future revenue, funding for our business and projects, margins, expenses, earnings, tax rates, cash flows, working capital, liquidity and other financial and accounting measures; the performance of obligations secured by our surety bonds; the amount, use and timing of future capital expenditures needed to fund our business plan and total anticipated capital expenditures for the current fiscal year; the impact of domestic and international tariffs on our business and the wider AC market; our ability to capitalize on potentially favorable market conditions; the adoption and scope of regulations to control certain chemicals in drinking water and other environmental concerns and the impact of such regulations on our customers' and our businesses, including any increase or decrease in demand and sales of our AC products resulting from such regulations; our near-term priorities and objectives and our long-term outlook regarding the growth of our business; and the impact of prices of competing power generation sources such as natural gas and renewable energy on demand for our products. These forward-looking statements involve risks and uncertainties. Actual events or results could differ materially from those discussed in the forward-looking statements as a result of various factors including, but not limited to, the timing and scope of new and pending regulations and any legal challenges to or extensions of compliance dates of them; the U.S. government's failure to promulgate new regulations or enforce existing regulations that benefit our business; changes in laws and regulations, accounting rules, prices, economic conditions and market demand; availability, cost of and demand for alternative energy sources and other technologies and their impact on coal-fired power generation in the U.S.; technical, start up and operational difficulties; competition within the industries in which the Company operates; risks associated with our debt financing; our inability to effectively and efficiently commercialize new products, including our GAC products; disruptions at any of our facilities, including by natural disasters or extreme weather; risks related to our information technology systems, including the risk of cyberattacks on our networks; failure to protect our intellectual property from infringement or claims that we have infringed on the intellectual property of others; our inability to obtain future financing or financing on terms that are favorable to us; our inability to ramp up our operations to effectively address recent and expected growth in our business; loss of key personnel; ongoing effects of the inflation and macroeconomic uncertainty, including from the new U.S. presidential administration, increased domestic and international tariffs, lingering effects of the pandemic and armed conflicts around the world, and such uncertainty's effect on market demand and input costs; availability of materials and equipment for our business; pending litigation; factors relating to our business strategy, goals and expectations concerning the acquisition of Arq Limited; our ability to maintain relationships with customers, suppliers and others with whom the Company does business and meet supply requirements; our results of operations and business generally; risks related to diverting management's attention from our ongoing business operations; costs related to the ongoing manufacturing of our products, including our GAC products; opportunities for additional sales of our AC products and end-market diversification; the rate of coal-fired power generation in the U.S.; the timing and cost of any future capital expenditures and the resultant impact to our liquidity and cash flows; and the other risk factors described in our filings with the SEC, including those described in Item 1A. Risk Factors of our Annual Report on Form 10-K for the year ended December 31, 2024. You are cautioned not to place undue reliance on the forward-looking statements and to consult filings we have made and will make with the SEC for additional discussion concerning risks and uncertainties that may apply to our business and the ownership of our securities. In addition to causing our actual results to differ, the factors listed above may cause our intentions to change from those statements of intention set forth in this presentation. Such changes in our intentions may also cause our results to differ. We may change our intentions, at any time and without notice, based upon changes in such factors, our assumptions, or otherwise. The forward-looking statements speak only as to the date of this presentation, and we disclaim any duty to update such statements unless required by law.
Included in this presentation are certain financial measures that are not calculated in accordance with U.S. generally accepted accounting principles ("GAAP") designed to supplement, and not substitute, the Company's financial information presented in accordance with GAAP. The non-GAAP measures as defined by the Company may not be comparable to similar non-GAAP measures presented by other companies. The presentation of such measures, which may include adjustments to exclude unusual or non-recurring items, should not be construed as an inference that the Company's future results or leverage will be unaffected by other unusual or non-recurring items. Please see the attached appendix for how we define these non-GAAP measures, a discussion of why we believe they are useful to investors, and certain limitations and reconciliations thereof to the most directly comparable GAAP measures.
\$35.1M
Reported 1% growth YoY; driven by strong pricing in foundational PAC business
\$25+ million Adjusted EBITDA improvement since Q3 2023 on a trailing twelve-month basis, driven by PAC turnaround and cost management
\$5.2M
6 th straight quarter of positive Adj. EBITDA; included negative offsets of several million dollars from low volume, early GAC ramp
Achieved initial commercial phase GAC production and sales; GAC market dynamics remain robust
+7% YoY
~15% average quarterly growth in PAC ASP since Q2 2023; strong visibility in PAC contract renewals into 2026+
Exploring blending or replacing Corbin GAC feedstock; advanced alternative product developments for Corbin feedstock

| \$ millions unless noted | Q3 2025 | Q3 2024 |
|---|---|---|
| Revenue | \$35.1 | \$34.8 |
| Gross Margin | 28.8% | 38.6% |
| Net (loss) income | (\$0.7) | \$1.6 |
| Adjusted EBITDA(1) | \$5.2 | \$5.9 |
| Cash & Restricted Cash | \$15.5 | \$57.4 |


| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|---|
| +16% | +15% | +15% | +14% | +13% | +9% | +7% |
+15%
Average YoY ASP increase1 +7%
YoY ASP increase in Q3
\$25M+
improvement in Adj. EBITDA2
Strong visibility in PAC contract renewals extends runway and sustainability into 2026 and beyond




1) Q2 2023 and Q2 2024 gross margin include impact of plant turnaround maintenance costs. Q4 2023 includes impact of \$4.7 million of take-or-pay revenue.


Applying same rigor and discipline used to turnaround PAC business to solving current GAC challenges










| As of | |||||
|---|---|---|---|---|---|
| (in thousands, except share data) | September 30, 2025 | December 31, 2024 | |||
| ASSETS | |||||
| Current assets: | |||||
| Cash | \$ | 7,026 | \$ | 13,516 | |
| Receivables, net | 14,364 | 14,876 | |||
| Inventories, net | 15,744 | 19,314 | |||
| Prepaid expenses and other current assets | 6,793 | 4,650 | |||
| Total current assets | 43,927 | 52,356 | |||
| Restricted cash, long-term | 8,467 | 8,719 | |||
| Property, plant and equipment, net of accumulated depreciation of \$32,429 and \$26,619, respectively | 180,724 | 178,564 | |||
| Other long-term assets, net | 44,828 | 44,729 | |||
| Total Assets | \$ | 277,946 | \$ | 284,368 | |
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||
| Current liabilities: | |||||
| Accounts payable and accrued expenses | \$ | 13,114 | \$ | 21,017 | |
| Revolving credit facility | 15,951 | 13,828 | |||
| Current portion of long-term debt obligations | 1,102 | 1,624 | |||
| Other current liabilities | 9,651 | 8,184 | |||
| Total current liabilities | 39,818 | 44,653 | |||
| Long-term debt obligations, net of current portion | 8,801 | 9,370 | |||
| Other long-term liabilities | 12,173 | 13,069 | |||
| Total Liabilities | 60,792 | 67,092 | |||
| Commitments and contingencies | |||||
| Stockholders' equity: | |||||
| Preferred stock: par value of \$0.001 per share, 50,000,000 shares authorized, none issued or outstanding | — | — | |||
| Common stock: par value of \$0.001 per share, 100,000,000 shares authorized, 47,307,611 and 46,639,930 shares issued, and 42,689,465 and 42,021,784 shares outstanding at September 30, 2025 and December 31, 2024, respectively |
47 | 47 | |||
| Treasury stock, at cost: 4,618,146 and 4,618,146 shares as of September 30, 2025 and December 31, 2024, respectively | (47,692) | (47,692) | |||
| Additional paid-in capital | 200,948 | 198,487 | |||
| Retained earnings | 63,851 | 66,434 | |||
| Total Stockholders' Equity | 217,154 | 217,276 | |||
| Total Liabilities and Stockholders' Equity | \$ | 277,946 | \$ | 284,368 |

| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||
|---|---|---|---|---|---|---|---|---|
| (in thousands, except per share data) | 2025 | 2024 | 2025 | 2024 | ||||
| Revenue | \$ | 35,074 | \$ | 34,774 | \$ | 90,905 | \$ | 81,919 |
| Cost of revenue, exclusive of depreciation and amortization | 24,965 | 21,339 | 61,363 | 52,279 | ||||
| Operating expenses: | ||||||||
| Selling, general and administrative | 4,624 | 8,058 | 16,595 | 22,735 | ||||
| Research and development | 2,566 | 787 | 6,137 | 3,341 | ||||
| Depreciation, amortization, depletion and accretion | 3,758 | 2,716 | 8,424 | 6,090 | ||||
| (Gain) loss on sale of assets | — | (154) | 118 | (154) | ||||
| Total operating expenses | 10,948 | 11,407 | 31,274 | 32,012 | ||||
| Operating (loss) income | (839) | 2,028 | (1,732) | (2,372) | ||||
| Other income (expense): | ||||||||
| Earnings from equity method investments | 83 | 127 | 238 | 127 | ||||
| Interest expense | (587) | (806) | (1,905) | (2,426) | ||||
| Other income | 690 | 268 | 816 | 931 | ||||
| Total other income (expense) | 186 | (411) | (851) | (1,368) | ||||
| (Loss) income before income taxes | (653) | 1,617 | (2,583) | (3,740) | ||||
| Income tax expense | — | — | — | 30 | ||||
| Net (loss) income | \$ | (653) | \$ | 1,617 | \$ | (2,583) | \$ | (3,770) |
| (Loss) income per common share: | ||||||||
| Basic | \$ | (0.02) | \$ | 0.04 | \$ | (0.06) | \$ | (0.11) |
| Diluted | \$ | (0.02) | \$ | 0.04 | \$ | (0.06) | \$ | (0.11) |
| Weighted-average number of common shares outstanding: | ||||||||
| Basic | 41,606 | 36,124 | 41,478 | 34,085 | ||||
| Diluted | 41,606 | 37,442 | 41,478 | 34,085 |

| (in thousands) | 2025 | |||
|---|---|---|---|---|
| 2024 | ||||
| Cash flows from operating activities | ||||
| Net loss | \$ | (2,583) | \$ | (3,770) |
| Adjustments to reconcile net loss to net cash provided by operating activities: | ||||
| Depreciation, amortization, depletion and accretion | 8,424 | 6,090 | ||
| Stock-based compensation expense | 2,523 | 2,185 | ||
| Operating lease expense | 1,797 | 1,518 | ||
| Amortization of debt discount and debt issuance costs | 266 | 450 | ||
| Loss (gain) on sale of long-term assets, net | 118 | (154) | ||
| Earnings from equity method investments | (238) | (127) | ||
| Other non-cash items, net | (704) | (113) | ||
| Changes in operating assets and liabilities: | ||||
| Receivables, net | 1,196 | (399) | ||
| Prepaid expenses and other assets | (2,326) | 1,812 | ||
| Inventories, net | 2,906 | 2,486 | ||
| Other long-term assets, net | (2,367) | (1,366) | ||
| Accounts payable and accrued expenses | (8,900) | (2,611) | ||
| Other current liabilities | 687 | 1,467 | ||
| Operating lease liabilities | (435) | (1,255) | ||
| Other long-term liabilities | (336) | (945) | ||
| Net cash provided by operating activities | 28 | 5,268 |

| Nine Months Ended September 30, | ||||
|---|---|---|---|---|
| (in thousands) | 2025 | 2024 | ||
| Cash flows from investing activities | ||||
| Acquisition of property, plant, equipment and intangible assets, net | \$ (7,793) |
\$ | (42,210) | |
| Acquisition of mine development costs | (292) | (167) | ||
| Distributions from equity method investees in excess of cumulative earnings | 238 | 127 | ||
| Proceeds from sale of property and equipment | — | 150 | ||
| Net cash used in investing activities | (7,847) | (42,100) | ||
| Cash flows from financing activities | ||||
| Borrowings on revolving credit facility | 96,683 | — | ||
| Repayments of revolving credit facility | (94,560) | — | ||
| Principal payments on notes payable | (592) | (404) | ||
| Principal payments on finance lease obligations | (392) | (838) | ||
| Repurchase of common stock to satisfy tax withholdings | (62) | (1,109) | ||
| Net proceeds from common stock issued in public offering | — | 26,659 | ||
| Net proceeds from common stock issued in private placement transactions | — | 14,951 | ||
| Net proceeds from common stock issued to related party | — | 800 | ||
| Net cash provided by financing activities | 1,077 | 40,059 | ||
| (Decrease) increase in Cash and Restricted Cash | (6,742) | 3,227 | ||
| Cash and Restricted Cash, beginning of period | 22,235 | 54,153 | ||
| Cash and Restricted Cash, end of period | \$ 15,493 |
\$ | 57,380 | |
| Supplemental disclosure of non-cash investing and financing activities: | ||||
| Change in accrued purchases for property and equipment | \$ 1,279 |
\$ | 8,199 | |
| Purchase of property and equipment through note payable | \$ — |
\$ | 258 |

To supplement our financial information presented in accordance with U.S. Generally Accepted Accounting Principles ("U.S. GAAP"), we provide certain supplemental financial measures, including EBITDA and Adjusted EBITDA, which are measurements that are not calculated in accordance with U.S. GAAP. EBITDA is defined as earnings before interest, taxes, depreciation and amortization, and Adjusted EBITDA is defined as EBITDA reduced by non-cash gains, increased by GAC Facility pre-production feedstock, share-based compensation expense, other non-cash losses and non-recurring costs and fees. EBITDA and Adjusted EBITDA should be considered in addition to, and not as a substitute for, net income (loss) in accordance with U.S. GAAP as a measure of performance. See below for a reconciliation from net income (loss), the nearest U.S. GAAP financial measure, to EBITDA and Adjusted EBITDA.
We believe that the EBITDA and Adjusted EBITDA measures are less susceptible to variances that affect our operating performance. We include these non-GAAP measures because management uses them in the evaluation of our operating performance, and believe they help to facilitate comparison of operating results between periods. We believe the non-GAAP measures provide useful information to both management and users of the financial statements by excluding certain expenses, gains, and losses which can vary widely across different industries or among companies within the same industry and may not be indicative of core operating results and business outlook.
Additionally, we have included these measures on a trailing twelve month ("TTM") basis. We believe that TTM Adjusted EBITDA is a useful measure of our operating performance over time. Management uses TTM Adjusted EBITDA to evaluate the trajectory of the business, assess the effectiveness of ongoing initiatives, and compare results across periods on a more consistent basis. By capturing the most recent twelve months of performance, TTM Adjusted EBITDA helps to smooth seasonal or timing-related variances and provides a clearer view of underlying operating trends. We believe this measure assists both management and users of the financial statements in understanding progress toward sustained profitability and operational improvement.
The following table reconciles net (loss) income, our most directly comparable as-reported financial measure calculated in accordance with U.S. GAAP, to EBITDA and Adjusted EBITDA.

| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||
|---|---|---|---|---|---|---|---|---|
| (in thousands) | 2025 | 2024 | 2025 | 2024 | ||||
| Net (loss) income | \$ | (653) | \$ | 1,617 | \$ | (2,583) | \$ | (3,770) |
| Depreciation, amortization, depletion and accretion | 3,758 | 2,716 | 8,424 | 6,090 | ||||
| Amortization of Upfront Customer Consideration | 127 | 127 | 381 | 381 | ||||
| Interest expense, net | 586 | 600 | 1,842 | 1,638 | ||||
| Income tax expense | — | — | — | 30 | ||||
| EBITDA | 3,818 | 5,060 | 8,064 | 4,369 | ||||
| Share-based compensation(1) | 1,053 | 750 | 2,523 | 2,185 | ||||
| GAC Facility pre-production feedstock(2) | 982 | — | 2,879 | — | ||||
| Gain on insurance proceeds(3) | (685) | — | (685) | — | ||||
| Financing costs | — | 228 | — | 228 | ||||
| (Gain) loss on sale of assets | — | (154) | 118 | (154) | ||||
| Adjusted EBITDA | \$ | 5,168 | \$ | 5,884 | \$ | 12,899 | \$ | 6,628 |
(1) Represents non-cash stock-based compensation expenses that are included within "Cost of revenue, exclusive of depreciation and amortization" and "Selling, general and administrative" expenses in the Condensed Consolidated Statements of Operations. Previously reported Adjusted EBITDA for the three and nine months ended September 30, 2024 has been revised to include non-cash stock-based compensation expense.

(2) Represents expenses related to feedstock utilized in pre-production testing of our GAC Facility during the three and nine months ended September 30, 2025 included within "Research and development" expense in the Condensed Consolidated Statements of Operations.
(3) Represents non-cash gain related to an insurance claim related to equipment at our Five Forks Mine during the three and nine months ended September 30, 2025 included within "Other income" in the Condensed Consolidated Statements of Operations. We received the proceeds in October 2025.
Trailing Twelve-Month Adjusted EBITDA: The following table reconciles trailing twelve month net loss, our most directly comparable as-reported financial measure calculated in accordance with U.S. GAAP, to Trailing Twelve Month EBITDA (loss) and Adjusted EBITDA (Adjusted EBITDA loss).
| Trailing Twelve Months Ended September 30, | ||||||
|---|---|---|---|---|---|---|
| (in thousands) | 2025 | 2024 | 2023 | |||
| Net loss | \$ | (3,922) | \$ | (480) | \$ | (18,706) |
| Depreciation, amortization, depletion and accretion | 10,928 | 9,357 | 8,927 | |||
| Amortization of Upfront Customer Consideration | 508 | 508 | 508 | |||
| Interest expense, net | 2,358 | 1,984 | 755 | |||
| Income tax (benefit) expense | (194) | 216 | 176 | |||
| EBITDA (loss) | \$ | 9,678 | \$ | 11,585 | \$ | (8,340) |
| Share-based compensation | 3,053 | 3,023 | 2,336 | |||
| GAC Facility pre-production feedstock | 2,879 | — | — | |||
| Loss on extinguishment of debt | 1,422 | — | — | |||
| Gain on insurance proceeds | (685) | — | — | |||
| Loss (gain) on sale of assets | 336 | (154) | — | |||
| Financing costs | 47 | 228 | — | |||
| Cash distributions from equity method investees | — | 111 | 1,832 | |||
| Equity earnings | — | (111) | (1,831) | |||
| Gain on change in estimate, asset retirement obligation | — | (37) | — | |||
| Gain on sale of Marshall Mine LLC | — | — | (2,695) | |||
| Adjusted EBITDA (Adjusted EBITDA loss) | \$ | 16,730 | \$ | 14,645 | \$ | (8,698) |


o Arq is a diversified, environmental technology company producing activated carbon products which reduce or reverse environmental liabilities, including PFAS or "forever chemicals". Our products enable a cleaner and safer planet
o Arq has the only fully domestic vertically integrated supply chain, improving water and air quality, using coal waste as a feedstock to remediate other way – contributing to America's energy independence
General Applications of Our Products

Soil, Water & Air Purification


2 Major Types of Activated Carbon
Powder Activated Carbon (PAC)
Granular Activated Carbon (GAC)


GAC from bituminous coal best at remediating PFAS and forever chemicals





Unique position with fully integrated domestic supply chain




Data suggest demand outpacing supply – Arq anticipates a 3-5x increase in demand over next 5 years not accounting for potential incremental demand growth from other sectors (e.g., biogas)

Of the ~153,000 public water systems in the U.S. estimated to require PFAS treatment facilities by 2030 (vs. 10% in 2023) 3
Estimated market size of U.S. drinking water PFAS treatment market by 2030 (~10x growth vs. 2023) 3
Estimated market penetration rate of GAC for PFAS treatment by 2030, driven by GAC advantages vs. alternative solutions 3
Replacement cycle for PFAS removal equipment estimated to increase ~2x (groundwater) and 4x (surface water) vs. historic usage 3
Estimated annual increase in GAC prices (2025-2027) 3

1 Reflects company estimates. Note: Arq estimates 10% increase on previous market data in 2024 & YoY through 2026; a 50% increase YoY in 2027 through 2029 – i.e. accelerating into final stages of compliance with new EPA regulations. Excludes any new entrants.
2Source: IHS. Note: Estimates based on 2022 data, and therefore compiled prior to latest EPA regulatory changes.
3 Goldman Sachs Research published on July 31, 2024.


1 - https://www.epa.gov/sciencematters/reducing-pfas-drinking-water-treatment-technologies
| PFAS Technology | Advantage | Disadvantage |
|---|---|---|
| Granular Activated Carbon | Lowest unit cost Strong PFAS removal performance Handles varied water quality Industry benchmark technology Broad adsorption spectrum Can be reactivated Flexible with other treatments Lowest capex requirement |
ꭗ Requires longer contact time ꭗ More frequent media change-outs |
| Ion Exchange | Smaller footprint No backwash needed |
ꭗ Higher unit cost ꭗ Majority of supply imported ꭗ Needs pre-filters due to higher headloss ꭗ Media disposal required ꭗ Sensitive to chlorine ꭗ Flow variability can affect performance |
| Reverse Osmosis / Nanofiltration | Compact footprint | ꭗ High cost and energy demand ꭗ Generates concentrated waste ꭗ Requires pre-treatment and more chemicals |
Source – Company data

GAC's role is as part of a larger biogas treatment system for purifying RNG by removing carbon dioxide, hydrogen sulfide, nitrogen, VOC and moisture
The RNG is passed directly through a GAC column to achieve this purification




30

Arq remains the only pure-play public company in the activated carbon market
Attractive growth market with concentrated pool of private competitors


Anthony Nathan, Arq Marc Silverberg, ICR [email protected]
8051 E. Maplewood Ave, Suite 210 Greenwood Village, CO 80111
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.